Pepto Bismol Suspension
NDC Package 69423-966-12
Package Information
Pepto Bismol (bismuth subsalicylate) suspension is shake well before useonly use dose cup providedadults and children 12 years and over:15 mL (1 dose) every ½ hour or 30 mL (2 doses) every hour as needed for diarrhea/traveler's diarrhea15 mL (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)do not exceed 8 doses (120 mL) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a suspension delivery system. Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 69423-966 and is authorized under FDA application M008.
Identification & Billing
- RxCUI: 211915 - Pepto-Bismol Max Strength 1050 MG in 30 mL Oral Suspension
- RxCUI: 211915 - bismuth subsalicylate 35 MG/ML Oral Suspension [Pepto-bismol]
- RxCUI: 211915 - Pepto-bismol 35 MG/ML Oral Suspension
- RxCUI: 211915 - Pepto-bismol 525 MG per 15 ML Oral Suspension
- RxCUI: 211915 - Pepto-bismol Max Strength 1050 MG per 30 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69423 - The Procter & Gamble Manufacturing Company
- 69423-966 - Pepto Bismol
- 69423-966-12 - 354 mL in 1 BOTTLE, PLASTIC
- 69423-966 - Pepto Bismol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69423-966-12 identifies a specific commercial package of 354 ml in 1 bottle, plastic of Pepto Bismol Ultra, a human over the counter drug labeled by The Procter & Gamble Manufacturing Company. This suspension is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on March 07, 2022. The current certification is valid through December 31, 2027.
How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69423096612. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.